EA
Therapeutic Areas
Opko Health Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NGENLA™ (somatrogon) | Pediatric Growth Hormone Deficiency | Market |
| RAYALDEE® (calcifediol) | Secondary Hyperparathyroidism in CKD | Market |
| MDX2004 | Advanced Cancers | Phase 1 |
| Multispecific Antibodies (with Regeneron) | Select Therapeutic Indications | Research |
| Oral Long-Acting PTH Tablet | Hypoparathyroidism | Preclinical |
| Nanoparticle Vaccines | Infectious Diseases | Research |